AngioDynamics (ANGO) Releases Quarterly Earnings Results
AngioDynamics (NASDAQ:ANGO) announced its earnings results on Wednesday. The company reported $0.18 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.12 by $0.06, ARN reports. The company had revenue of $94.07 million for the quarter, compared to the consensus estimate of $93.65 million. During the same quarter last year, the company posted $0.07 earnings per share. AngioDynamics’s revenue was up 4.5% compared to the same quarter last year. AngioDynamics updated its Q1 guidance to $0.08-0.12 EPS and its FY15 guidance to $0.64-0.70 EPS.
Several analysts have recently commented on the stock. Analysts at Canaccord Genuity upgraded shares of AngioDynamics from a “hold” rating to a “buy” rating in a research note on Thursday, June 19th. They now have a $20.00 price target on the stock, up previously from $16.25. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of AngioDynamics in a research note on Thursday, May 22nd. They now have a $15.00 price target on the stock. Finally, analysts at Raymond James cut their price target on shares of AngioDynamics from $19.00 to $18.00 in a research note on Friday, May 16th.
AngioDynamics (NASDAQ:ANGO) traded up 2.55% during mid-day trading on Wednesday, hitting $15.28. The stock had a trading volume of 175,568 shares. AngioDynamics has a 52 week low of $10.84 and a 52 week high of $19.00. The stock’s 50-day moving average is $15.06 and its 200-day moving average is $15.31. The company has a market cap of $539.0 million and a P/E ratio of 147.52.
AngioDynamics, Inc designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.